Terms: = Prostate cancer AND RAF1, Raf-1, 5894, P04049, ENSG00000132155, c-Raf, CRAF
112 results:
1. A rare Ewing-like small round cell tumor in prostate: a case report and literature review.
Wang Z; Ye J; Hu J; Zhang N; Yuan Y
J Cancer Res Clin Oncol; 2024 Mar; 150(3):110. PubMed ID: 38427070
[TBL] [Abstract] [Full Text] [Related]
2. Caffeic acid phenethyl ester suppresses EGFR/FAK/Akt signaling, migration, and tumor growth of prostate cancer cells.
Tseng JC; Wang BJ; Wang YP; Kuo YY; Chen JK; Hour TC; Kuo LK; Hsiao PJ; Yeh CC; Kao CL; Shih LJ; Chuu CP
Phytomedicine; 2023 Jul; 116():154860. PubMed ID: 37201366
[TBL] [Abstract] [Full Text] [Related]
3. Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer.
Kong D; Ye C; Zhang C; Sun X; Wang F; Chen R; Xiao G; He S; Xu J; Rao X; Ai J; Gao X; Li H; Su L
J Exp Clin Cancer Res; 2023 Feb; 42(1):45. PubMed ID: 36759880
[TBL] [Abstract] [Full Text] [Related]
4. Identification of fusions with potential clinical significance in melanoma.
Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
[TBL] [Abstract] [Full Text] [Related]
5. Elevated serum CEA is associated with liver metastasis and distinctive circulating tumor DNA alterations in patients with castration-resistant prostate cancer.
Bray AW; Duan R; Malalur P; Drusbosky LM; Gourdin TS; Hill EG; Lilly MB
Prostate; 2022 Sep; 82(13):1264-1272. PubMed ID: 35766303
[TBL] [Abstract] [Full Text] [Related]
6. Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors.
Ali IH; Abdel-Mohsen HT; Mounier MM; Abo-Elfadl MT; El Kerdawy AM; Ghannam IAY
Bioorg Chem; 2022 Sep; 126():105883. PubMed ID: 35636123
[TBL] [Abstract] [Full Text] [Related]
7. RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-craf-MAPK pathway.
Sun F; Wang X; Hu J; Liu J; Wang X; Jia W; Yu Z; Gao L; Dou B; Zhao R; Feng T; Wang X; Zhang W; Liu H; Liu K; Shao Y; Dong X; Han B
Oncogene; 2022 Jun; 41(23):3239-3250. PubMed ID: 35508542
[TBL] [Abstract] [Full Text] [Related]
8. Gephyromycin C, a novel small-molecule inhibitor of heat shock protein Hsp90, induces G2/M cell cycle arrest and apoptosis in PC3 cells in vitro.
Ding WJ; Ji YY; Jiang YJ; Ying WJ; Fang ZY; Gao TT
Biochem Biophys Res Commun; 2020 Oct; 531(3):377-382. PubMed ID: 32800334
[TBL] [Abstract] [Full Text] [Related]
9. Systemic review on B-Raf
Chavda J; Bhatt H
Eur J Med Chem; 2020 Nov; 206():112675. PubMed ID: 32798788
[TBL] [Abstract] [Full Text] [Related]
10. Simulated Microgravity Influences VEGF, MAPK, and PAM Signaling in prostate cancer Cells.
Hybel TE; Dietrichs D; Sahana J; Corydon TJ; Nassef MZ; Wehland M; Krüger M; Magnusson NE; Bauer J; Utpatel K; Infanger M; Grimm D; Kopp S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32070055
[TBL] [Abstract] [Full Text] [Related]
11. MYSM1-AR complex-mediated repression of Akt/c-raf/GSK-3β signaling impedes castration-resistant prostate cancer growth.
Sun J; Hu X; Gao Y; Tang Q; Zhao Z; Xi W; Yang F; Zhang W; Song Y; Song B; Wang T; Wang H
Aging (Albany NY); 2019 Nov; 11(22):10644-10663. PubMed ID: 31761786
[TBL] [Abstract] [Full Text] [Related]
12. A Multifunctional Therapy Approach for cancer: Targeting raf1- Mediated Inhibition of Cell Motility, Growth, and Interaction with the Microenvironment.
Zhang L; Pattanayak A; Li W; Ko HK; Fowler G; Gordon R; Bergan R
Mol Cancer Ther; 2020 Jan; 19(1):39-51. PubMed ID: 31582531
[TBL] [Abstract] [Full Text] [Related]
13. Immune profiling of human prostate epithelial cells determined by expression of p38/TRAF-6/ERK MAP kinases pathways.
Bouraoui Y; Achour M; Royuela M; Oueslati R
Kaohsiung J Med Sci; 2018 Mar; 34(3):125-133. PubMed ID: 29475459
[TBL] [Abstract] [Full Text] [Related]
14. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
[TBL] [Abstract] [Full Text] [Related]
15. Commentary on "Integrative clinical genomics of advanced prostate cancer". Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM.Cell. 21 May 2015;161(5):1215-1228.
Freedland SJ; Aronson WJ
Urol Oncol; 2017 Aug; 35(8):535. PubMed ID: 28623072
[TBL] [Abstract] [Full Text] [Related]
16. Anti-androgen 2-hydroxyflutamide modulates cadherin, catenin and androgen receptor phosphorylation in androgen-sensitive LNCaP and androgen-independent PC3 prostate cancer cell lines acting via PI3K/Akt and MAPK/ERK1/2 pathways.
Górowska-Wójtowicz E; Hejmej A; Kamińska A; Pardyak L; Kotula-Balak M; Dulińska-Litewka J; Laidler P; Bilińska B
Toxicol In Vitro; 2017 Apr; 40():324-335. PubMed ID: 28163245
[TBL] [Abstract] [Full Text] [Related]
17. Dishevelled segment polarity protein 3 (DVL3): a novel and easily applicable recurrence predictor in localised prostate adenocarcinoma.
Kim PJ; Park JY; Kim HG; Cho YM; Go H
BJU Int; 2017 Sep; 120(3):343-350. PubMed ID: 28107606
[TBL] [Abstract] [Full Text] [Related]
18. SH003 induces apoptosis of DU145 prostate cancer cells by inhibiting ERK-involved pathway.
Choi YJ; Choi YK; Lee KM; Cho SG; Kang SY; Ko SG
BMC Complement Altern Med; 2016 Dec; 16(1):507. PubMed ID: 27927199
[TBL] [Abstract] [Full Text] [Related]
19. ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.
Davis JE; Xie X; Guo J; Huang W; Chu WM; Huang S; Teng Y; Wu G
Oncotarget; 2016 Jun; 7(26):39834-39845. PubMed ID: 27213581
[TBL] [Abstract] [Full Text] [Related]
20. Whole Genomic Copy Number Alterations in Circulating Tumor Cells from Men with Abiraterone or Enzalutamide-Resistant Metastatic Castration-Resistant prostate cancer.
Gupta S; Li J; Kemeny G; Bitting RL; Beaver J; Somarelli JA; Ware KE; Gregory S; Armstrong AJ
Clin Cancer Res; 2017 Mar; 23(5):1346-1357. PubMed ID: 27601596
[No Abstract] [Full Text] [Related]
[Next]
